title: Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
authors.affiliation: Department of Medical Oncology,  Institut Gustave Roussy, Villejuif,  France.
authors.forename: B
authors.initials: B
authors.lastname: Escudier
authors.forename: T
authors.initials: T
authors.lastname: Eisen
authors.forename: C
authors.initials: C
authors.lastname: Porta
authors.forename: J J
authors.initials: JJ
authors.lastname: Patard
authors.forename: V
authors.initials: V
authors.lastname: Khoo
authors.forename: F
authors.initials: F
authors.lastname: Algaba
authors.forename: P
authors.initials: P
authors.lastname: Mulders
authors.forename: V
authors.initials: V
authors.lastname: Kataja
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002292:Carcinoma, Renal Cell / Q000175:diagnosis* / Q000235:genetics / Q000556:secondary / Q000628:therapy; D003131:Combined Modality Therapy; D019468:Disease Management; D006801:Humans; D007680:Kidney Neoplasms / Q000175:diagnosis* / Q000235:genetics / Q000473:pathology / Q000628:therapy; D058990:Molecular Targeted Therapy; D009154:Mutation; D009367:Neoplasm Staging; D011379:Prognosis; D018570:Risk Assessment; D016896:Treatment Outcome; D047368:Tumor Burden